HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sterol regulatory element-binding protein-1c knockdown protected INS-1E cells from lipotoxicity.

AbstractOBJECTIVE:
The reduction in insulin secretory capacity and beta-cell mass has been attributed, at least partially, to lipotoxicity, which may contribute to the development of type 2 diabetes. Chronic free fatty acids (FFA) exposure impairs pancreatic beta-cell function and induces beta-cell apoptosis. This study is to elucidate the underlying molecular mechanisms.
RESEARCH DESIGN AND METHODS:
We exposed INS-1E pancreatic beta-cell line to palmitate or oleate, and measured the glucose stimulated insulin secretion (GSIS). The effect of FFA on sterol regulatory element-binding protein (SREBP)-1c lipogenic pathway, and expression of genes involved in beta-cell functions, including AMPK (AMP-activated protein kinase), UCP-2 (uncoupling protein-2), IRS-2 (insulin receptor substrate-2), PDX-1 (pancreatic duodenal homeobox-1), GLUT-2 (glucose transporter-2) and B cell lymphoma/leukaemia-2 (Bcl-2) were investigated. Apoptosis of these exposed cells was determined by MitoCapture, Annexin V-Cy3 or terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling assay. Cell lipid accumulation was measured by oil red O staining or TG extraction. Also SREBP-1c expression knockdown were used.
RESULTS:
FFA treatment resulted in SREBP-1c overexpression, impaired GSIS, lipid accumulation, apoptosis of INS-1E cells. In addition, the expression of lipogenic genes and UCP-2 were upregulated, but AMPK, IRS-2, PDX-1, GLUT-2 and Bcl-2 were downregulated in the exposed cells. However, these lipotoxic effects of FFA were largely prevented by induction of a SREBP-1c small interfering RNA.
CONCLUSIONS:
These data suggest a strong correlation between FFA treatment and SREBP-1c activation in INS-1E cells. SREBP-1c might be a major factor responsible for beta-cell lipotoxicity, and SREBP-1c knockdown could protect INS-1E cells from lipotoxicity, which is implicating a therapeutic potential for treating diabetes related to lipotoxicity.
AuthorsJ Li, X Liu, X Ran, J Chen, X Li, W Wu, H Huang, H Huang, Y Long, J Liang, J Cheng, H Tian
JournalDiabetes, obesity & metabolism (Diabetes Obes Metab) Vol. 12 Issue 1 Pg. 35-46 (Jan 2010) ISSN: 1463-1326 [Electronic] England
PMID19758361 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Fatty Acids, Nonesterified
  • Insulin
  • Palmitates
  • RNA, Small Interfering
  • Sterol Regulatory Element Binding Protein 1
  • Triglycerides
  • Oleic Acid
  • Glucose
Topics
  • Animals
  • Apoptosis (physiology)
  • Blotting, Western
  • Cell Line
  • Diabetes Mellitus, Type 2 (metabolism)
  • Fatty Acids, Nonesterified (pharmacology)
  • Gene Expression
  • Gene Knockdown Techniques
  • Glucose (pharmacology)
  • Humans
  • Insulin (metabolism)
  • Insulin Secretion
  • Insulin-Secreting Cells (cytology, drug effects, metabolism)
  • Lipid Metabolism (physiology)
  • Oleic Acid (pharmacology)
  • Palmitates (pharmacology)
  • RNA, Small Interfering (isolation & purification)
  • Sterol Regulatory Element Binding Protein 1 (genetics, metabolism)
  • Transcription, Genetic (drug effects)
  • Triglycerides (isolation & purification)
  • Up-Regulation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: